Cargando…
Enhancing Cystic Fibrosis Immune Regulation
In cystic fibrosis (CF), sustained infection and exuberant inflammation results in debilitating and often fatal lung disease. Advancement in CF therapeutics has provided successful treatment regimens for a variety of clinical consequences in CF; however effective means to treat the pulmonary infecti...
Autores principales: | van Heeckeren, Anna M., Sutton, Morgan T., Fletcher, David R., Hodges, Craig A., Caplan, Arnold I., Bonfield, Tracey L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155373/ https://www.ncbi.nlm.nih.gov/pubmed/34054509 http://dx.doi.org/10.3389/fphar.2021.573065 |
Ejemplares similares
-
Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment
por: Sutton, Morgan T., et al.
Publicado: (2016) -
Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the “First in Cystic Fibrosis” Phase I Clinical Trial (CEASE-CF)
por: Bonfield, Tracey L., et al.
Publicado: (2023) -
Preclinical Modeling for Therapeutic Development in Cystic Fibrosis
por: Bonfield, Tracey L.
Publicado: (2020) -
Donor‐defined mesenchymal stem cell antimicrobial potency against nontuberculous mycobacterium
por: Bonfield, Tracey L., et al.
Publicado: (2021) -
CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis
por: Hisert, Katherine B., et al.
Publicado: (2020)